Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings

Cancer Detection and Prevention

Volumn 31, Issue 1, 2007, Pages 50-58

  Sauter, Edward R ^a   Wagner Mann, Colette ^a   Ehya, Hormoz ^b   Klein Szanto, Andres ^b  

^a University of Missouri   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Basic fibroblast growth factor; Breast cancer; Cytology; DNA index; Hormone replacement therapy; Human glandular kallikrein 2; Nipple aspirate fluid; Predictive markers; Prostate specific antigen; Proteins; S phase fraction

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL MARKER; CELL MARKER; KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN; TUMOR MARKER;

ADULT; ANAMNESIS; ARTICLE; BIRTH CONTROL; BREAST BIOPSY; BREAST CANCER; BREAST DISCHARGE; CANCER DIAGNOSIS; CANCER MODEL; CYTOLOGY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST NEOPLASMS; DNA, NEOPLASM; EXTRACELLULAR FLUID; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LOGISTIC MODELS; MENOPAUSE; MIDDLE AGED; MISSOURI; NIPPLES; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; RISK FACTORS; S PHASE; SENSITIVITY AND SPECIFICITY; TISSUE KALLIKREINS; TUMOR MARKERS, BIOLOGICAL;

EID: 33847663891     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2006.12.004     Document Type: Article

References (23)

1. Shah V.I., Raju U., Chitale D., Deshpande V., Gregory N., and Strand V. False-negative core needle biopsies of the breast: an analysis of clinical, radiologic, and pathologic findings in 27 concecutive cases of missed breast cancer. Cancer 97 8 (2003) 1824-1831
2. Choi Y.D., Cho Y.H., Lee J.H., Nam J.H., Juhng S.W., and Choi C. Analysis of fine needle aspiration cytology of the breast: a review of 1297 cases and correlation with histologic diagnoses. Acta Cytol 48 6 (2004) 801-806
3. Winer E.P., Morrow M., Osborne C.K., and Haris J.R. Cancer of the breast. In: DeVita V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer: principles & practice of oncology. 6 ed. (2001), Lippincott Williams & Wilkins, Philadelphia 1651-1716
4. Sauter E.R., Ross E., Daly M., Klein-Szanto A., Engstrom P.F., and Sorling A. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer 76 4 (1997) 494-501
5. Sauter E.R., Ehya H., Babb J., Diamandis E., Daly M., Klein-Szanto A., et al. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br J Cancer 81 7 (1999) 1222-1227
6. Sauter E.R., Ehya H., Mammen A., and Klein G. Nipple aspirate cytology and pathologic parameters predict residual cancer and nodal involvement after excisional breast biopsy. Br J Cancer 85 12 (2001) 1952-1957
7. Sauter E.R., Welch T., Magklara A., Klein G., and Diamandis E.P. Ethnic variation in kallikrein expression in nipple aspirate fluid. Int J Cancer 100 6 (2002) 678-682
8. Folkman J., and Klagsbrun M. Angiogenic factors. Science 235 4787 (1987) 442-447
9. Folkman J., Shing Y., and Angiogenesis. J Biol Chem 267 16 (1992) 10931-10934
10. Nguyen M., Watanabe H., Budson A.E., Richie J.P., Hayes D.F., and Folkman J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86 5 (1994) 356-361
11. Nguyen M. Angiogenic factors as tumor markers. Invest New Drugs 15 1 (1997) 29-37
12. Liu Y., Wang J.L., Chang H., Barsky S.H., and Nguyen M. Breast-cancer diagnosis with nipple fluid bFGF. Lancet 356 9229 (2000) 567
13. Hsiung R., Zhu W., Klein G., Qin W., Rosenberg A., Park P., et al. High basic fibroblast growth factor levels in nipple aspirate fluid are correlated with breast cancer. Cancer J 8 4 (2002) 303-310
14. Sudbo J., Kildal W., Risberg B., Koppang H.S., Danielsen H.E., and Reith A. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 344 17 (2001) 1270-1278
15. Krishnamurthy S., Sneige N., Thompson P.A., Marcy S.M., Singletary S.E., Cristofanilli M., et al. Nipple aspirate fluid cytology in breast carcinoma. Cancer 99 2 (2003) 97-104
16. King E.B., Chew K.L., Petrakis N.L., and Ernster V.L. Nipple aspirate cytology for the study of breast cancer precursors. J Natl Cancer Inst 71 6 (1983) 1115-1121
17. Sauter E.R., Ehya H., Schlatter L., and MacGibbon B. Ductoscopic cytology to detect breast cancer. Cancer J 10 1 (2004) 33-41 discussion 15-6
18. Dooley W.C., Ljung B.M., Veronesi U., Cazzaniga M., Elledge R.M., O'Shaughnessy J.A., et al. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 93 21 (2001) 1624-1632
19. Ries L.A.G., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., and Edwards BK. SEER Cancer Statistics Review 1973-1996 (1999), National Cancer Institute, Bethesda MD (NIH publication No 99-2789)
20. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347 9017 (1996, June 22) 1713-1727
21. Chlebowski R.T., Hendrix S.L., Langer R.D., Stefanick M.L., Gass M., Lane D., et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the women's health initiative randomized trial. JAMA 289 24 (2003) 3243-3253
22. Chao C., Edwards M.J., Abell T., Wong S.L., Simpson D., and McMasters K.M. Palpable breast carcinomas: a hypothesis for clinically relevant lymphatic drainage in sentinel lymph node biopsy. Breast J 9 1 (2003) 26-32
23. Shen K.W., Wu J., Lu J.S., Han Q.X., Shen Z.Z., Nguyen M., et al. Fiberoptic ductoscopy for patients with nipple discharge. Cancer 89 7 (2000) 1512-1519